1Levine RL,Wadleigh M,Cools J,et al.Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell . 2005
2Papayannopoulou T.Mechanisms of stem-/progenitor-cell mobilization: the anti-VLA-4 paradigm. Seminars in Hematology . 2000
3Merup M,Lazarevic V,Nahi H,et al.Swedish Group for Myeloproliferative Disorders.Different outcome of allogeneic transplantation in myelofibrosis using conventional or reducedintensity conditioning regimens. British Journal of Haematology . 2006
4Mesa R A,Hanson C A,Rajkumar S V,et al.Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia. Blood . 2000
5Rajantie,J.,Sale,G.E.,Deeg,H.J.Adverse effect of severe marrow fibrosis on hematologic recovery after chemoradiotherapy and allogeneic bone marrow transplantation. Blood . 1986
6Nicolaus Krö,ger, Tatjana Zabelina, Heike Schieder, Jens Panse, Francis Ayuk, Norbert Stute, Natalja Fehse, Olga Waschke, Boris Fehse, Hans Michael Kvasnicka<s.Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis. British Journal of Haematology . 2005
7Rondelli,D.,Barosi,G.,Bacigalupo,A.Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate-or high-risk patients with myelofibrosis with myeloid metaplasia. Blood . 2005
8Li ZH,Gooley T,Appelbaum FR,et al.Splenectomy and hemopoietic stem cell transplantation for myelofibrosis. Blood . 2001
9DM Kerbauy,TA Gooley,GE Sale,ME Flowers,KC Doney,GE Georges.Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia. Biology of Blood and Marrow Transplantation . 2007
10Drachman JG.Role of thrombopoietin in hematopoietic stem cell and progenitor regulation. Current Opinion in Hematology . 2000
